Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer

Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer

Abstract Background Lung cancer is a major cause of cancer‐related mortality worldwide, with a 5‐year survival rate of approximately 22%. Cisplatin is one of the standard first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC), but its efficacy is often limited by the development o...

Full description

Bibliographic Details
Main Authors: Somayeh Hashemi Sheikhshabani, Paratoo Modarres, Soudeh Ghafouri‐Fard, Zeinab Amini‐Farsani, Lavin Khodaee, Nasibeh Shaygan, Zahra Amini‐Farsani, Mir Davood Omrani
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
BER
cisplatin resistance
EMT
microarray
non‐small cell lung cancer
PARP3
Online Access:https://doi.org/10.1002/cnr2.1970

Internet

https://doi.org/10.1002/cnr2.1970

Similar Items